S14.2 Favorable outcome of patients with inflammatory neuropsychiatric lupus treated with immunosuppression
Main Authors: | T Huizinga, M Kloppenburg, M Steup-Beekman, H Middelkoop, R Fronczek, N van der Wee, R Monahan, L Beaart-Van De Voorde, J De Bresser, J Eikenboom, G Terwindt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-10-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
S14.3 Cognitive dysfunction is common but associates weakly with quality of life in patients with lupus and neuropsychiatric symptoms
by: T Huizinga, et al.
Published: (2022-10-01) -
Clinical outcome in patients with suspected inflammatory neuropsychiatric lupus treated with immunosuppression: an observational cohort study
by: Margreet Kloppenburg, et al.
Published: (2023-01-01) -
To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosus
by: Margreet Kloppenburg, et al.
Published: (2022-07-01) -
Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
by: Margreet Kloppenburg, et al.
Published: (2022-04-01) -
Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go?
by: César Magro-Checa, et al.
Published: (2018-12-01)